This was Citius second try for FDA approval, after the regulator rejected Lymphir in July 2023, outlining the need for enhanced product resting requirements. In its resubmitted data package, the company included findings from the from the Phase III Study 302 trial, where treatment with the drug led to an objective response rate of 36.2%, with 8.7% reaching complete response
This blend combines BPC-157, a natural repair peptide that supports soft tissue and wound healing, with Thymosin Beta-4, which aids in tendon repair, joint health, and faster recovery
However, what is known is that humans cannot survive more than a few days without water
Thus the GSH/GSSG ratio is important to normal functioning and is a likely contributor to cellular signaling pathways by activating or inactivating key thiol-containing enzymes
The results held even for patients who did not have a B12 deficiency